Inventiva IVEVF Stock
Inventiva Price Chart
Inventiva IVEVF Financial and Trading Overview
| Inventiva stock price | 5.33 USD |
| Previous Close | 5.33 USD |
| Open | 5.5 USD |
| Bid | 4.47 USD x 20000 |
| Ask | 5.33 USD x 10000 |
| Day's Range | 5.5 - 5.5 USD |
| 52 Week Range | 2.28 - 5.75 USD |
| Volume | 340 USD |
| Avg. Volume | 37 USD |
| Market Cap | 1.15B USD |
| Beta (5Y Monthly) | 0.883 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.21 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IVEVF Valuation Measures
| Enterprise Value | 1.24B USD |
| Trailing P/E | N/A |
| Forward P/E | -2.669903 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 169.97687 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 183.129 |
| Enterprise Value/EBITDA | -9.345 |
Trading Information
Inventiva Stock Price History
| Beta (5Y Monthly) | 0.883 |
| 52-Week Change | 133.77% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 5.75 USD |
| 52 Week Low | 2.28 USD |
| 50-Day Moving Average | 5.3 USD |
| 200-Day Moving Average | 4.23 USD |
IVEVF Share Statistics
| Avg. Volume (3 month) | 37 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 208.95M |
| Float | 135.14M |
| Short Ratio | N/A |
| % Held by Insiders | 14.32% |
| % Held by Institutions | 60.99% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -6710.68% |
| Gross Margin | 99.67% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.079% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 6.76M USD |
| Revenue Per Share (ttm) | 0.04 USD |
| Quarterly Revenue Growth (yoy) | -89.90% |
| Gross Profit (ttm) | 6.74M USD |
| EBITDA | -132497000 USD |
| Net Income Avi to Common (ttm) | -354137984 USD |
| Diluted EPS (ttm) | -2.21 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 99.84M USD |
| Total Cash Per Share (mrq) | 0.48 USD |
| Total Debt (mrq) | 230.89M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.159 |
| Book Value Per Share (mrq) | -0.1733894 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -104884000 USD |
| Levered Free Cash Flow (ttm) | -200711632 USD |
Profile of Inventiva
| Country | United States |
| State | N/A |
| City | Daix |
| Address | 50 rue de Dijon |
| ZIP | 21121 |
| Phone | 33 3 80 44 75 00 |
| Website | https://inventivapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 69 |
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Q&A For Inventiva Stock
What is a current IVEVF stock price?
Inventiva IVEVF stock price today per share is 5.33 USD.
How to purchase Inventiva stock?
You can buy IVEVF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Inventiva?
The stock symbol or ticker of Inventiva is IVEVF.
Which industry does the Inventiva company belong to?
The Inventiva industry is Biotechnology.
How many shares does Inventiva have in circulation?
The max supply of Inventiva shares is 208.95M.
What is Inventiva Price to Earnings Ratio (PE Ratio)?
Inventiva PE Ratio is now.
What was Inventiva earnings per share over the trailing 12 months (TTM)?
Inventiva EPS is -2.21 USD over the trailing 12 months.
Which sector does the Inventiva company belong to?
The Inventiva sector is Healthcare.